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The number of muscarinic acetylcholine r ceptors (MAChRs), as detected by binding of [3H]quinuclidinyl benzilate 
(QNB), was investigated under conditions which promote protein phosphorylation. I cubation of a crude heart mem- 
brane preparation i the presence of ATP/Mg 2+ reduced MAChR number by 50~. Incubation with polymyxin B, an 
inhibitor of protein kinase C, blocked the effect of ATP/Mg z+ and increased MAChR number by 74%. 
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1. INTRODUCTION 
Pro longed exposure o f  intact heart  cells to 
chol inergic agonists results in a biphasic reduct ion 
in the number  o f  muscar inic acetylchol ine recep- 
tors (MAChRs)  detectable by radio labeled an- 
tagonists [1]. At  least part  of  the apparent  
reduct ion o f  MAChRs  is due to persistent binding 
o f  the unlabeled agonist.  The loss of  detectable 
MAChRs  correlates with decreased sensitivity o f  
the heart to cholinergic agonists. This 
phenomenon of  MAChR desensit izat ion is poor ly  
understood.  One possible mechanism is that desen- 
s it izat ion results f rom phosphory lat ion  of  either 
the MAChR or a closely associated protein.  In sup- 
port  of  this hypothesis it has been reported that in 
vitro condit ions which favor protein phosphory la-  
t ion result in a loss of  MAChRs  [2-4].  Recently, 
Kwatra  and Hosey [5] have found that t reatment 
o f  hearts with the agonist carbachol  leads to 
10-12- fo ld  increases in phosphory lat ion of  the 
MAChR.  In this report  we show that polymyxin B 
(PMB),  a selective inhibitor of  protein kinase C 
Correspondence address: T.L. Creazzo, Department of 
Anatomy, Medical College of Georgia, Augusta, GA 
30912-2000, USA 
[6], prevents the loss of  MAChRs  which results 
f rom incubat ion of  crude heart  membrane 
preparat ions under condit ions which favor protein 
phosphory lat ion.  
2. MATERIALS  AND METHODS 
Fresh adult chicken hearts were a gift from Amick's Farm, 
Batesburg, SC. l-[3H]Quinuclidinyl benzilate (QNB) was pur- 
chased from Amersham/Searle. Atropine sulfate, adenine 
nucleotides and protein kinase A inhibitor were purchased from 
Sigma. Polymyxin B was purchased from United States 
Biochemical Corporation. 
2.1. Tissue preparation 
A crude membrane preparation was prepared inthe following 
manner. The ventricles were coursely chopped, washed and 
homogenized with a Polytron in 100 mg tissue/ml of 50 mM 
Tris-HC1, pH 7.4 (buffer). The homogenate was centrifuged at 
1000 x g for 10 min and the pellet discarded. The supernate 
was centrifuged at 21000 x g for 30 rain. The supernate was 
discarded and the pellet resuspended in buffer to yield approx. 
2 mg protein per ml. All steps were carried out at 4°C. The 
preparation was frozen at -80°C until used. 
2.2. Assay of ffHIQNB binding 
[3H]QNB binding was assayed and analyzed according to 
Cl;eazzo and Hartzell [7] except hat non-specific binding was 
determined using 10/~M atropine sulfate. Assays were carried 
out overnight at room temperature in triplicate and terminated 
by filtration. Each assay tube contained 2ml of buffer with 
Published by Elsevier Science Publishers B.V. (Biomedical Division) 
00145793/88/$3.50 © 1988 Federation of European Biochemical Societies 175 
Volume 242, number 1 FEBS LETTERS December 1988 
500 pM [3H]QNB (970/0 saturation) and 50/zl of homogenate 
(50-100/zg protein). Other additions are noted in the figure 
legends. Data from multiple experiments are expressed as 
means _+ SE. 
3. RESULTS 
To test whether MAChR number is affected by 
conditions which would favor phosphorylation by
protein kinases membranes were incubated in the 
presence of various adenine nucleotides (fig. 1). In- 
cubation with adenine nucleotides in the absence 
of Mg 2+ produced either no effect or a slight eleva- 
tion of MAChR binding to [3H]QNB. In the 
presence of Mg 2+, ATP reduced the apparent 
number of MAChRs by 50%. In contrast, ADP 
and AMP reduced MAChRs only slightly when in 
the presence of Mg 2+. Similarly, the non- 
hydrolyzable ATP analog, AMP-PNP, had little 
effect. Scatchard analysis showed that the 
nucleotides or Mg 2+ had no effect on [3H]QNB- 
binding affinity (Kd -- 11 pM, not shown). These 
results suggest that protein phosphorylation 
reduces the number of MAChRs that can be 
detected by [3H]QNB. 
To test further the possibility that phosphoryla- 
tion reduces MAChR-binding sites, membranes 
were incubated with PMB, a specific inhibitor of 
protein kinase C (PKC) [61. Fig.2A shows that 
PMB by itself increased the number of MAChRs in 
a dose-dependent fashion. In the presence of ATP 
and Mg 2+, PMB similarly increased MAChR sites 
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Fig.l. Effect of adenine nucleotides with and without Mg 2+ on 
[3HIQNB binding. (Open bars) Effects of 5 mM ATP, AI~P 
and AMP and 1 mM AMP-PNP; (filled bars) effects of 
nucleotides plus 5 mM MgC12. The results were normalized to 
controls containing either no additions or 5 mM MgC12. The 
number of experiments is given above each bar. 
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Fig.2. (A) PMB dose response. (Open squares) Incubation with 
PMB only; (filled squares) incubation with PMB plus 5 mM 
ATP and MgCI2. (B) Effect of incubation of 100/~M PMB (n = 
3) and 10 units/ml cAMP-dependent protein kinase inhibitor 
(PKA-I; n = 2) and 5 mM ATP and MgCI2. The results were 
normalized to controls containing 5 mM ATP and Mg ~+ 
without inhibitors. 
in a dose-dependent manner though not as effec- 
tively as with PMB alone. Whether or not in the 
presence of ATP and Mg 2+, the maximum number 
of detectable MAChR-binding sites in the presence 
of 100/~M PMB was about 18 pM. Fig.2B in- 
dicates a 74% mean increase in the number of 
MAChRs with 100/~M PMB in the presence of 
ATP and Mg 2+. In contrast, an inhibitor of 
cAMP-dependent protein kinase [8] reduced 
MAChRs by 14%. 
4. DISCUSSION 
The results demonstrate that incubation of crude 
ventricle membranes with PMB, a specific in- 
hibitor of PKC [6], substantially increases the 
number of MAChRs detectable with [3H]QNB. 
Secondly, PMB inhibited the reduction of 
MAChRs that occurred in the presence of 
176 
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ATP/Mg 2÷. The cAMP-dependent protein kinase 
inhibitor (Walsh Inhibitor) [8], however, caused a 
slight reduction in MAChR number. These results 
suggest wo possible mechanisms. The first is that 
PKC phosphorylation of the MAChR prevents 
binding of cholinergic ligands. The second 
possibility is that PKC phosphorylation activates a 
protein phosphatase which catalyzes dephospho- 
rylation of the MAChR. This in turn would cause 
release of persistently bound acetylcholine, thereby 
allowing detection by [3H]QNB. Under this 
scenario the observed loss of MAChRs in the 
presence of added ATP/Mg 2÷ (fig. 1) may be due 
to some other protein kinase activity. The data 
presented here do not distinguish between these 
two possible mechanisms. 
Though PKC activity is Ca 2÷ dependent i was 
not necessary to add Ca 2+ in order to observe 
MAChR loss in ATP /Mg 2+. The addition of 
200/zM Ca 2÷ to the assay did not enhance MAChR 
loss over ATP /Mg 2÷ alone (not shown). This is not 
surprising since contaminating Ca 2÷ is probably 
10-20/zM or more. The Km for Ca 2÷ stimulated 
PKC phosphorylation of histone H I  is 35/~M 
which decreases to 5-12/zM in the presence of 
phospholipid cofactors [9]. Also, the presence of 
other membrane lipid co factors, such as 
diglycerides, lowers the Km for Ca 2÷ to levels 
below 1/~M [10-11]. As already indicated by this 
discussion we cannot exclude the possibility that 
the reduction of MAChRs, observed in the 
presence of ATP /Mg 2÷, was due to a kinase other 
than PKC. 
It is interesting that PMB by itself increases 
MAChR binding without the addition of 
ATP /Mg 2÷. One explanation is that PMB inhibits 
phosphorylation of the MAChR by the particulate 
PKC and ATP/Mg 2+ already present in the crude 
membrane preparation. This is a reasonable 
assumption if the Km for ATP /Mg 2+ phosphoryla- 
tion with PKC is in the low micromolar ange; 
such as, for example, the Km for PKC 
phosphorylation of histone H1 (4.4/zM) [12]. 
The data discussed in this report support the 
hypothesis that PKC-catalyzed protein phospho- 
rylation plays a major role in MAChR desensitiza- 
tion and/or  down regulation. Consistent with this 
hypothesis is a recent report indicating that PKC 
inhibits MAChR-modulated Ca 2÷ release and en- 
try in human salivary cells [13]. 
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